These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 19348145)

  • 1. [Prevention of contrast-induced nephropathy and management of high-risk patients].
    Marenzi G
    G Ital Cardiol (Rome); 2009 Feb; 10(2):88-96. PubMed ID: 19348145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrast-induced nephropathy.
    Bartorelli AL; Marenzi G
    J Interv Cardiol; 2008 Feb; 21(1):74-85. PubMed ID: 18086132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast-induced nephropathy.
    Marenzi G; Cabiati A; Milazzo V; Rubino M
    Intern Emerg Med; 2012 Oct; 7 Suppl 3():S181-3. PubMed ID: 23073854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast media induced nephropathy: definition, incidence, outcome, pathophysiology, risk factors and prevention.
    Feldkamp T; Kribben A
    Minerva Med; 2008 Apr; 99(2):177-96. PubMed ID: 18431326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of contrast induced nephropathy: recommendations for the high risk patient undergoing cardiovascular procedures.
    Schweiger MJ; Chambers CE; Davidson CJ; Blankenship J; Bhalla NP; Block PC; Dervan JP; Gasperetti C; Gerber L; Kleiman NS; Krone RJ; Phillips WJ; Siegel RM; Uretsky BF; Laskey WK
    Catheter Cardiovasc Interv; 2007 Jan; 69(1):135-40. PubMed ID: 17139671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of contrast-induced nephropathy: experience in patients undergoing cardiovascular intervention.
    McCullough P
    Catheter Cardiovasc Interv; 2006 Mar; 67(3):335-43. PubMed ID: 16489569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors and therapy strategies for contrast-induced nephropathy.
    Toprak O; Cirit M
    Ren Fail; 2006; 28(5):365-81. PubMed ID: 16825085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevention of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention.
    Cavusoglu E; Chhabra S; Marmur JD; Kini A; Sharma SK
    Minerva Cardioangiol; 2004 Oct; 52(5):419-32. PubMed ID: 15514576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New usage for an old drug: acetylcysteine for contrast-induced nephropathy].
    Asher I; Hammerman A; Sthoeger Z
    Harefuah; 2005 Sep; 144(9):642-6; 675. PubMed ID: 16218537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Contrast-induced nephropathy].
    Santos RO; Malvar B; Silva R; Ramalho V; Pessegueiro P; Amoedo M; Aniceto J; Pires C
    Acta Med Port; 2011; 24(5):809-20. PubMed ID: 22525634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of two hemofiltration protocols for prevention of contrast-induced nephropathy in high-risk patients.
    Marenzi G; Lauri G; Campodonico J; Marana I; Assanelli E; De Metrio M; Grazi M; Veglia F; Fabbiocchi F; Montorsi P; Bartorelli AL
    Am J Med; 2006 Feb; 119(2):155-62. PubMed ID: 16443418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical and renal consequences of contrast-induced nephropathy.
    Finn WF
    Nephrol Dial Transplant; 2006 Jun; 21(6):i2-10. PubMed ID: 16723349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast-induced nephropathy: the wheel has turned 360 degrees.
    Thomsen HS; Morcos SK; Barrett BJ
    Acta Radiol; 2008 Jul; 49(6):646-57. PubMed ID: 18568557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast-induced nephropathy.
    Narang R; Sakhare M; Bahl VK
    Indian Heart J; 2004; 56(1):13-20. PubMed ID: 15129784
    [No Abstract]   [Full Text] [Related]  

  • 15. Contrast-induced nephropathy among Israeli hospitalized patients: incidence, risk factors, length of stay and mortality.
    Shema L; Ore L; Geron R; Kristal B
    Isr Med Assoc J; 2009 Aug; 11(8):460-4. PubMed ID: 19891232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk prediction of contrast-induced nephropathy.
    McCullough PA; Adam A; Becker CR; Davidson C; Lameire N; Stacul F; Tumlin J;
    Am J Cardiol; 2006 Sep; 98(6A):27K-36K. PubMed ID: 16949378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention and treatment of contrast-induced nephropathy.
    Al-Ghonaim M; Pannu N
    Tech Vasc Interv Radiol; 2006 Jun; 9(2):42-9. PubMed ID: 17482099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of contrast-induced nephropathy.
    McCullough PA; Sandberg KR
    Rev Cardiovasc Med; 2003; 4 Suppl 5():S3-9. PubMed ID: 14668704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemofiltration in the prevention of radiocontrast agent induced nephropathy.
    Marenzi G; Bartorelli AL
    Minerva Anestesiol; 2004 Apr; 70(4):189-91. PubMed ID: 15173694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence-based emergency medicine review. Prevention of contrast-induced nephropathy in the emergency department.
    Sinert R; Doty CI
    Ann Emerg Med; 2007 Sep; 50(3):335-45, 345.e1-2. PubMed ID: 17512638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.